325
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Recurrent Episodes with Serous Retinal Detachment and Anterior Uveitis in a Patient Using Nivolumab (Anti -PD-1 Antibody) Therapy: A case report and literature review

ORCID Icon, ORCID Icon & ORCID Icon
Pages 794-799 | Received 19 Jan 2021, Accepted 12 Mar 2021, Published online: 29 Mar 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yinchen Shen, Yuanyuan Gong & Li Su. (2023) Diagnostic Challenges in PD-1 Inhibitor Induced Panuveitis in a Teenage Girl with Chest Soft Tissue Sarcoma - A Case Report. Ocular Immunology and Inflammation 0:0, pages 1-4.
Read now

Articles from other publishers (5)

Andrew C. Lin, Soo J. Park, Gregory A. Daniels & Shyamanga Borooah. (2023) Pigmentary retinopathy associated with immune therapy for advanced cutaneous melanoma. American Journal of Ophthalmology Case Reports 30, pages 101849.
Crossref
Yixiang Zhan, Weipeng Zhao, Kemin Ni, Zhaoce Liu, Yanjun Su, Xichuan Li, Heng Zhang & Chunze Zhang. (2022) Case report: Camrelizumab associated with central retinal vein occlusion. Frontiers in Immunology 13.
Crossref
Florence Chaudot, Pascal Sève, Antoine Rousseau, Alexandre Thibault Jacques Maria, Pierre Fournie, Pierre Lozach, Jeremy Keraen, Marion Servant, Romain Muller, Baptiste Gramont, Sara Touhami, Habeeb Mahmoud, Pierre-Antoine Quintart, Stéphane Dalle, Olivier Lambotte, Laurent Kodjikian & Yvan Jamilloux. (2022) Ocular Inflammation Induced by Immune Checkpoint Inhibitors. Journal of Clinical Medicine 11:17, pages 4993.
Crossref
Jacob S Heng, Jenna M Kim, D Kyle Jones, Kathleen M Stoessel, Sarah A Weiss, Mario Sznol, Harriet M Kluger, Scott D Walter, Niki A Silverstein & Renelle Pointdujour-Lim. (2022) Autoimmune retinopathy with associated anti-retinal antibodies as a potential immune-related adverse event associated with immunotherapy in patients with advanced cutaneous melanoma: case series and systematic review. BMJ Open Ophthalmology 7:1, pages e000889.
Crossref
. (2021) Nivolumab. Reactions Weekly 1882:1, pages 379-379.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.